86. Pulmonary arterial hypertension Clinical trials / Disease details

Clinical trials : 1,205 / Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000001709	2009/02/01	16/02/2009	Multikinase Inhibitor (Tyrosine and Serine/Threonine Kinase Inhibitor) for the Treatment of Severe P ...	Multikinase Inhibitor (Tyrosine and Serine/Threonine Kinase Inhibitor) for the Treatment of Severe P ...	pulmonary arterial hypertension	administration of sorafenib, which is the multikinase inhibitor (tyrosineand serine/threoninekinase ...	Medical Education Center, School of Medicine, Keio University	NULL	Pending	20years-old	Not applicable	Male and Female	10	Not selected	Japan
2	NCT00452218 (ClinicalTrials.gov)	March 2007	26/3/2007	Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)	Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)	Pulmonary Arterial Hypertension	Drug: Sorafenib	University of Chicago	Bayer	Completed	18 Years	N/A	Both	12	Phase 1	United States

First Previous1Next Last